Gérald Marit

17.7k total citations · 2 hit papers
193 papers, 8.6k citations indexed

About

Gérald Marit is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Gérald Marit has authored 193 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Hematology, 60 papers in Oncology and 45 papers in Genetics. Recurrent topics in Gérald Marit's work include Multiple Myeloma Research and Treatments (61 papers), Hematopoietic Stem Cell Transplantation (47 papers) and Chronic Myeloid Leukemia Treatments (40 papers). Gérald Marit is often cited by papers focused on Multiple Myeloma Research and Treatments (61 papers), Hematopoietic Stem Cell Transplantation (47 papers) and Chronic Myeloid Leukemia Treatments (40 papers). Gérald Marit collaborates with scholars based in France, United States and Canada. Gérald Marit's co-authors include Michel Attal, Josy Reiffers, Philippe Moreau, Denis Caillot, Thierry Façon, Jean‐Luc Harousseau, Hervé Avet‐Loiseau, Margaret Macro, Bertrand Coiffier and Hervé Tilly and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Gérald Marit

190 papers receiving 8.4k citations

Hit Papers

Long-term outcome of pati... 2010 2026 2015 2020 2010 2017 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
    2010 1.1k citations Bertrand Coiffier, Catherine Thiéblemont et al. Blood profile →
  2. Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis
    2017 392 citations Cyrille Hulin, Philippe Moreau et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gérald Marit 5.9k 3.3k 3.3k 2.2k 1.8k 193 8.6k
Pellegrino Musto 5.6k 0.9× 4.3k 1.3× 3.5k 1.1× 2.4k 1.1× 1.6k 0.9× 386 9.7k
Miloslav Beran 5.2k 0.9× 2.2k 0.7× 1.8k 0.5× 3.4k 1.6× 1.7k 0.9× 106 8.5k
Ramón García‐Sánz 5.5k 0.9× 4.0k 1.2× 3.7k 1.1× 3.1k 1.4× 2.4k 1.4× 337 9.6k
Norbert Ifrah 7.3k 1.2× 3.9k 1.2× 3.5k 1.1× 1.7k 0.8× 1.2k 0.7× 231 11.4k
Meir Wetzler 5.0k 0.8× 3.0k 0.9× 2.1k 0.6× 2.1k 1.0× 702 0.4× 245 8.6k
Joseph O. Moore 3.3k 0.6× 1.8k 0.5× 1.9k 0.6× 1.5k 0.7× 997 0.6× 148 6.6k
Jordi Esteve 4.9k 0.8× 2.6k 0.8× 1.8k 0.5× 1.8k 0.8× 1.2k 0.7× 262 7.6k
Sylvie Castaigné 6.0k 1.0× 5.1k 1.5× 2.1k 0.6× 1.5k 0.7× 1.3k 0.8× 168 9.2k
Christian Récher 5.0k 0.8× 4.4k 1.3× 1.9k 0.6× 1.8k 0.8× 854 0.5× 299 9.1k
Ingemar Turesson 6.2k 1.0× 4.0k 1.2× 3.5k 1.1× 1.8k 0.8× 860 0.5× 148 8.3k

Countries citing papers authored by Gérald Marit

Since Specialization
Citations

This map shows the geographic impact of Gérald Marit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérald Marit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérald Marit more than expected).

Fields of papers citing papers by Gérald Marit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gérald Marit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérald Marit. The network helps show where Gérald Marit may publish in the future.

Co-authorship network of co-authors of Gérald Marit

This figure shows the co-authorship network connecting the top 25 collaborators of Gérald Marit. A scholar is included among the top collaborators of Gérald Marit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gérald Marit. Gérald Marit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mesguich, Charles, et al.. (2020). Choline PET/CT in Multiple Myeloma. Cancers. 12(6). 1394–1394. 13 indexed citations
3.
4.
Mesguich, Charles, Cyrille Hulin, V. Latrabe, et al.. (2020). Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma. Annals of Hematology. 99(12). 2869–2880. 21 indexed citations
5.
Damaj, Gandhi, Florent Malard, Cyrille Hulin, et al.. (2011). Efficacy of bendamustine in relapsed/refractory myeloma patients: results from the French compassionate use program. Leukemia & lymphoma. 53(4). 632–634. 33 indexed citations
6.
Avet‐Loiseau, Hervé, Xavier Leleu, Murielle Roussel, et al.. (2010). Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p). Journal of Clinical Oncology. 28(30). 4630–4634. 298 indexed citations
7.
Coiffier, Bertrand, Catherine Thiéblemont, Éric Van Den Neste, et al.. (2010). Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood. 116(12). 2040–2045. 1071 indexed citations breakdown →
8.
Orsi, Laurent, Xavier Troussard, Alain Monnereau, et al.. (2007). Occupation and Lymphoid Malignancies: Results From a French Case-Control Study. Journal of Occupational and Environmental Medicine. 49(12). 1339–1350. 18 indexed citations
9.
Rousselot, Philippe, Françoise Huguet, Delphine Réa, et al.. (2006). Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. Blood. 109(1). 58–60. 387 indexed citations
10.
Picard, Stéphane, Karine Titier, Gabriel Étienne, et al.. (2006). Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood. 109(8). 3496–3499. 468 indexed citations
11.
Morschhauser, Franck, Stéphane Depil, Éric Jourdan, et al.. (2006). Phase II study of gemcitabine–dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma. Annals of Oncology. 18(2). 370–375. 34 indexed citations
12.
Feugier, Pierre, J.-M. Virion, Hervé Tilly, et al.. (2003). Incidence and risk factors for central nervous system occurrencein elderly patients with diffuse large-B-cell lymphoma: influenceof rituximab. Annals of Oncology. 15(1). 129–133. 190 indexed citations
13.
Mahon, F.-X., X. Delbrel, Pascale Cony‐Makhoul, et al.. (2002). Follow-Up of Complete Cytogenetic Remission in Patients With Chronic Myeloid Leukemia After Cessation of Interferon Alfa. Journal of Clinical Oncology. 20(1). 214–220. 52 indexed citations
14.
Accoceberry, Isabelle, François‐Xavier Weill, Philippe Agapé, et al.. (1999). Intérêt du dosage sérique de l'antigène galactomannane par méthode ELISA chez les patients présentant un risque d'aspergillose invasive dans un service d'hématologie. Journal de Mycologie Médicale. 12(3). 131–135. 2 indexed citations
15.
Reiffers, Josy, Gérald Marit, & Jean-Michel Boiron. (1995). Role of High-Dose Therapy with Peripheral Blood Progenitor Cell Support in Multiple Myeloma. Journal of Hematotherapy. 4(2). 121–125. 4 indexed citations
16.
Jl, Harousseau, Michel Attal, Marine Diviné, et al.. (1995). Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.. PubMed. 15(6). 963–9. 42 indexed citations
17.
Reiffers, Josy, C. Fabères, JM Boiron, et al.. (1994). Peripheral Blood Progenitor Cell Transplantation in 118 Patients with Hematological Malignancies: Analysis of Factors Affecting the Rate of Engraftment. Journal of Hematotherapy. 3(3). 185–191. 42 indexed citations
18.
Cordonnier, Charlotte, Guy Leverger, Benoı̂t Schlemmer, et al.. (1994). [Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].. PubMed. 36(4). 289–91. 1 indexed citations
19.
Marit, Gérald, et al.. (1993). Mixed chimerism after sex-mismatched allogeneic BMT: evaluation of two molecular techniques.. PubMed. 11(1). 27–31. 10 indexed citations
20.
Cowen, D., Pierre Richaud, Gérald Marit, et al.. (1992). Regimen-related toxicity in patients undergoing BMT with total body irradiation using a sweeping beam technique.. PubMed. 10(6). 515–9. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pellegrino Musto Breakdown of academic impact, for papers by Miloslav Beran Breakdown of academic impact, for papers by Ramón García‐Sánz Breakdown of academic impact, for papers by Norbert Ifrah Breakdown of academic impact, for papers by Meir Wetzler Breakdown of academic impact, for papers by Joseph O. Moore Breakdown of academic impact, for papers by Jordi Esteve Breakdown of academic impact, for papers by Sylvie Castaigné Breakdown of academic impact, for papers by Christian Récher Breakdown of academic impact, for papers by Ingemar Turesson
Rankless by CCL
2026